Navigation Links
Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
Date:1/4/2012

er $30 million in non-dilutive funding through government and NGO grants/contracts. Under his leadership the company has advanced vaccine programs for cervical dysplasia, HIV, and influenza that are now in Phase I/II clinical studies. He currently serves as the principal investigator on an NIAID funded HVDDT contract for the development of HIV vaccines and an MVI-PATH funded program for the development of malaria vaccines. While at VGX, Dr. Sardesai was instrumental in formulating and directing the company's development and growth strategy through its mergers with Advisys, Inc. & Inovio Biomedical. He also had direct P&L responsibility for the company's cGMP contract manufacturing facility prior to its divestiture.

Prior to VGX, Dr. Sardesai was the founder and President of NVision Consulting Inc., a strategy consulting firm focused on entrepreneurial life sciences companies, and he served as Director R&D at Fujirebio Diagnostics, Inc. At Fujirebio, Dr. Sardesai oversaw R&D and expansion of the oncology portfolio. Products developed under his leadership include new-to-the-world tests for mesothelioma (MESOMARK™), bladder cancer and a multi-marker test for ovarian cancer. He has authored over 40 peer-reviewed publications, presented at over 75 invited lectures and presentations, and filed several patents. Dr. Sardesai received a Ph.D. in Chemistry from the California Institute of Technology and an MBA from the Wharton School of the University of Pennsylvania, where he was the recipient of the Shils-Zeidman Award in Entrepreneurship. He completed fellowships at Scripps Research Institute and Massachusetts Institute of Technology. Dr. Sardesai received his bachelors and masters in Chemistry from the Indian Institute of Technology, Bombay.

About Inovio Pharmaceuticals, Inc.

Inovio is developing its revolutionary vaccines to extend the profound medical benefits of the 20th century's immune-system-stimulating va
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Inovio Pharmaceuticals DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
2. Inovio Pharmaceuticals Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
3. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
4. Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
5. Inovio Pharmaceuticals Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease
6. Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
7. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
11. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), ... biosimilar therapeutics, today announced that it will be presenting ... on March 2 nd at 3pm PST. Patrick Lucy, ... panel discussing the current state of the biosimilar industry ... For more information on CALBIO 2015 ...
(Date:2/27/2015)... 2015   PureTech , a science and technology ... products and technologies in the healthcare sector, announced today ... and Member of the Board of Directors of Sanofi, ... has been a pleasure to know Chris for many ... be working together more closely now," said Dr. ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive Vice ... driven by key research advancements and product launches across ... Bank of America Merrill Lynch 2015 Global Agriculture Conference. ... of building grain supplies the last two years, long-term ... the pace of the last decade, when demand for ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... Record Fiscal 2010 Financial Results -- CHENGDU, China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Calif., Sept. 29 Rigel Pharmaceuticals, Inc. (Nasdaq: ... $25 million from AstraZeneca for the fulfillment of two ... regarding the clinical development of fostamatinib (R788), a novel ... of the phase 3 clinical program with fostamatinib in ...
... Stem cells that glow like fireflies could someday help doctors ... In his University of Central Florida lab, Steven Ebert engineered ... The "firefly" stem cells glow brighter and brighter as they ... and where the stem cells are working. Researchers are ...
Cached Biology Technology:Tianyin Reports Record Fiscal 2010 Financial Results 2Tianyin Reports Record Fiscal 2010 Financial Results 3Tianyin Reports Record Fiscal 2010 Financial Results 4Tianyin Reports Record Fiscal 2010 Financial Results 5Tianyin Reports Record Fiscal 2010 Financial Results 6Tianyin Reports Record Fiscal 2010 Financial Results 7Tianyin Reports Record Fiscal 2010 Financial Results 8Tianyin Reports Record Fiscal 2010 Financial Results 9Tianyin Reports Record Fiscal 2010 Financial Results 10Tianyin Reports Record Fiscal 2010 Financial Results 11Tianyin Reports Record Fiscal 2010 Financial Results 12Tianyin Reports Record Fiscal 2010 Financial Results 13Rigel Earns Milestone Payments From AstraZeneca 2Rigel Earns Milestone Payments From AstraZeneca 3
(Date:2/24/2015)... -- This report analyzes the worldwide markets for Face and Voice ... Voice Biometrics. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Latin America . Annual estimates and forecasts are ... analysis is provided for these markets. Market data and analytics are ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... state of the world,s oceans and fisheries led to inaccurate ... according to new analysis by an international team led by ... it,s like flipping a coin, half the time you get ... wrong answer," said Trevor Branch, a UW assistant professor of ...
... Coaching happens just about everywhere, and every day, with ... to smoothly functioning organizations, better productivity and potentially more ... Doctors or nurses can connect more with patients. So, ... goal, and it has been a major topic of ...
... Physicians caring for patients with sepsis may soon have ... Research led by Dr. Karel Tyml and his colleagues ... Institute have found that vitamin C can not only prevent ... Sepsis is caused by a bacterial infection that can begin ...
Cached Biology News:Scientists question indicator of fisheries health, evidence for 'fishing down food webs' 2Scientists question indicator of fisheries health, evidence for 'fishing down food webs' 3Coaching with compassion can 'light up' human thoughts 2Coaching with compassion can 'light up' human thoughts 3Coaching with compassion can 'light up' human thoughts 4Vitamin C: A potential life-saving treatment for sepsis 2
albumin from bovine serum (BSA), BODIPY® FL conjugate...
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
... (6-28) (human, bovine, porcine, rat) ... (VIP) receptor antagonist. This carboxy-terminal ... be twofold more potent than ... antagonists. Storage: ...
... Services are uniquely positioned to ... current competitive environment. Invitrogens experts ... express, purify, and characterize proteins ... Studies, Activity Assays, X-ray Crystallography, ...
Biology Products: